These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9886316)

  • 1. Prothrombotic changes in children with sickle cell disease: relationships to cerebrovascular disease and transfusion.
    Liesner R; Mackie I; Cookson J; McDonald S; Chitolie A; Donohoe S; Evans J; Hann I; Machin S
    Br J Haematol; 1998 Dec; 103(4):1037-44. PubMed ID: 9886316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced thrombin generation in children with sickle cell disease.
    Peters M; Plaat BE; ten Cate H; Wolters HJ; Weening RS; Brandjes DP
    Thromb Haemost; 1994 Feb; 71(2):169-72. PubMed ID: 8191393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin generation and cell-dependent hypercoagulability in sickle cell disease.
    Whelihan MF; Lim MY; Mooberry MJ; Piegore MG; Ilich A; Wogu A; Cai J; Monroe DM; Ataga KI; Mann KG; Key NS
    J Thromb Haemost; 2016 Oct; 14(10):1941-1952. PubMed ID: 27430959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.
    Nishank SS; Singh MP; Yadav R
    Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein C and protein S activity in sickle cell disease and stroke.
    Tam DA
    J Child Neurol; 1997 Jan; 12(1):19-21. PubMed ID: 9010791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced protein C levels--a contributory factor for stroke in sickle cell disease.
    Khanduri U; Gravell D; Christie BS; Al Lamki Z; Zachariah M; Cherian E
    Thromb Haemost; 1998 Apr; 79(4):879-80. PubMed ID: 9569210
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombin generation reveals high procoagulant potential in the plasma of sickle cell disease children.
    Noubouossie DF; Lê PQ; Corazza F; Debaugnies F; Rozen L; Ferster A; Demulder A
    Am J Hematol; 2012 Feb; 87(2):145-9. PubMed ID: 22052675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural coagulation inhibitors (protein C, protein S, antithrombin) in patients with sickle cell anemia in a steady state.
    Bayazit AK; Kilinç Y
    Pediatr Int; 2001 Dec; 43(6):592-6. PubMed ID: 11737735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Chronic Blood Transfusion on Biomarkers of Coagulation Activation and Thrombin Generation in Sickle Cell Patients at Risk for Stroke.
    Hyacinth HI; Adams RJ; Greenberg CS; Voeks JH; Hill A; Hibbert JM; Gee BE
    PLoS One; 2015; 10(8):e0134193. PubMed ID: 26305570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid antibodies, proteins C and S, and coagulation changes in sickle cell disease.
    Westerman MP; Green D; Gilman-Sachs A; Beaman K; Freels S; Boggio L; Allen S; Zuckerman L; Schlegel R; Williamson P
    J Lab Clin Med; 1999 Oct; 134(4):352-62. PubMed ID: 10521081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications.
    Tantawy AA; Adly AA; Ismail EA; Habeeb NM; Farouk A
    Platelets; 2013; 24(8):605-14. PubMed ID: 23249216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sickle cell disorders and chronic intravascular haemolysis are associated with low plasma heparin cofactor II.
    Porter JB; Young L; Mackie IJ; Marshall L; Machin SJ
    Br J Haematol; 1993 Mar; 83(3):459-65. PubMed ID: 8485052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of thromboelastography and thrombin generation in assessing the prothrombotic state of adults with sickle cell disease.
    Wijnberge M; Parmar K; Kesse-Adu R; Howard J; Cohen AT; Hunt BJ
    Thromb Res; 2017 Oct; 158():113-120. PubMed ID: 28888622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation activation and fibrinolytic imbalance in subjects with idiopathic antiphospholipid antibodies--a crucial role for acquired free protein S deficiency.
    Ames PR; Tommasino C; Iannaccone L; Brillante M; Cimino R; Brancaccio V
    Thromb Haemost; 1996 Aug; 76(2):190-4. PubMed ID: 8865529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma protein C levels in children with sickle cell disease.
    Karayalcin G; Lanzkowsky P
    Am J Pediatr Hematol Oncol; 1989; 11(3):320-3. PubMed ID: 2782560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormalities of coagulation and fibrinolysis in homozygous sickle cell disease.
    Nsiri B; Gritli N; Bayoudh F; Messaoud T; Fattoum S; Machghoul S
    Hematol Cell Ther; 1996 Jul; 38(3):279-84. PubMed ID: 8974793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased protein S activity in sickle cell disease.
    Marfaing-Koka A; Boyer-Neumann C; Wolf M; Leroy-Matheron C; Cynober T; Tchernia G
    Nouv Rev Fr Hematol (1978); 1993 Aug; 35(4):425-30. PubMed ID: 8414963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue factor-positive monocytes expression in children with sickle cell disease: clinical implication and relation to inflammatory and coagulation markers.
    Ragab SM; Soliman MA
    Blood Coagul Fibrinolysis; 2016 Dec; 27(8):862-869. PubMed ID: 26761587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombin, protein S and protein C and antiphospholipid antibodies in systemic lupus erythematosus.
    Costallat LT; Ribeiro CC; Annichino-Bizzacchi JM
    Sangre (Barc); 1998 Oct; 43(5):345-8. PubMed ID: 9868323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heamostatic and genetic predisposing factors for stroke in children with sickle cell anemia.
    Mourad H; Fadel W; El Batch M; Rowisha M
    Egypt J Immunol; 2008; 15(1):25-37. PubMed ID: 20306667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.